Skip to main content
OpenTrials

Clinical trial condition

Chronic Lymphocytic Leukemia (CLL)

Explore clinical trials studying Chronic Lymphocytic Leukemia (CLL). Study availability and eligibility vary by location and protocol.

72 public trials 20 recruiting studies
Refine in advanced search Browse all conditions

Chronic Lymphocytic Leukemia (CLL) trial results

Recruiting

A Clinical Study Evaluating the Safety and Efficacy of GT801 Injection in Adult Patients With Relapsed/Refractory CD19-positive B-cell Hematologic Malignancies and Autoimmune Hemolytic Anemia

NCT07205315

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Autoimmune, +31 more
Locations
  • Zhengzhou Yihe Hospital Zhengzhou, Henan, China
  • Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Recruiting

Study of the Use of Venetoclax in Participants With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting

NCT03342144

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +14 more
Locations
  • Universitaetsklinikum St. Poelten /ID# 221152 Sankt Pölten, Lower Austria, Austria
  • Medizinische Universitaet Graz /ID# 221155 Graz, Styria, Austria
  • Landeskrankenhaus Salzburg-Universitaetsklinikum der PMU (LKH) /ID# 221153 Salzburg, Austria
  • Hanusch Krankenhaus /ID# 221151 Vienna, Austria
View all 70 locations
View Trial Details
Recruiting

A Study of NX-5948 in Adults With CLL/SLL Previously Treated With a Bruton's Tyrosine Kinase Inhibitor and a B-cell Lymphoma-2 Inhibitor (DAYBreak CLL-201)

NCT07221500

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +16 more
Locations
  • City of Hope Duarte, California, United States
  • Colorado Blood Institute Denver, Colorado, United States
  • University of Miami Coral Gables, Florida, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
View all 32 locations
View Trial Details
Recruiting

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

NCT05131022

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 62 locations
View Trial Details
Recruiting

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

NCT06528301

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia (CLL), Disease Attributes, +19 more
Locations
  • City of Hope Duarte, California, United States
  • The David and Etta Jonas Center for Cellular Therapy Chicago, Illinois, United States
  • Washington University School of Medicine/Siteman Cancer Center St Louis, Missouri, United States
  • University of Nebraska Medical Center Omaha, Nebraska, United States
View Trial Details

Related conditions